$ALTO

NATHAN GILBERT E purchased 10,000 shares of Alto Ingredients, Inc. (ALTO) at $3.93 on 2026-09-14.

Alto Ingredients (ALTO) reported higher high-quality alcohol volumes (+3.6M gallons YoY) in Q2 2026, but narrower premiums over ethanol reduced revenues by $2.9M. Hedging strategies offset some impact, limiting net premium decline to 2 cents/gallon. Profitability increased modestly despite softer premiums. Shares fell 5.6% in the past month, underperforming peers. Forward P/S ratio is 0.34, below industry average 3.33. Earnings estimates declined 27.8% and 66.3% for 2026 and 2027, respectively.

Alto Ingredients (ALTO) reported Q2 2026 results in an earnings call. Net sales rose to $245.7M, adjusted EBITDA was $23.7M, and net income attributable to common stockholders was $11.4M ($0.15/diluted share). Full-year Section 45Z guidance is $15M to $16M. Management discussed capacity expansion, CO2 storage, and a $50M at-the-market equity program.

NATHAN GILBERT E purchased 50,000 shares of Alto Ingredients, Inc. (ALTO) at $4.15 ($0.21M total) on 2026-08-11.

Alto Ingredients, Inc. (ALTO) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01. Entry into a Material Definitive Agreement. On August 5, 2026, Alto Ingredients, Inc. (the “Company”) entered into an At-The-Market Issuance Sales Agreement (the “Sales Agreement”) with Craig-Hallum Capital Group LLC (the “Designated Agent”), The Benchmark Company, LLC

Alto Ingredients, Inc. (ALTO) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Alto Ingredients, Inc. Reports Second Quarter 2026 Results Q2 2026 Gross Profit of $16.6 Million Increased $18.6 Million Q2 2026 Net Income of $11.4 Million, or $0.15 per Share, Improved $22.7 Million Q2 2026 Adjusted EBITDA of $23.7 Million Improved $23.9 Million Pe

The FBI reported July firearm background checks rose 9.3% to 2,194,563 versus July 2025, the second straight monthly increase. The article links checks to firearm demand and notes exposure for Smith & Wesson (SWBI) and Sturm Ruger (RGR). It also lists analyst rating/price-target updates for OCUL, RKLB, VELO, and ONDS, plus upcoming earnings expectations for several stocks.

Alto Ingredients, according to the company, is partnering with the Heart of Illinois Port District and the City of Pekin on a $16M Illinois River project to improve product flow from its Pekin campus to barges for export. Funding includes an $11M federal grant request, $1M state request, and about $4M from Alto. Federal grant results expected by year end, with completion around 2029.

Alto Ingredients, Inc. (ALTO) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-10.1 2 ea029568801ex10-1.htm ALTO INGREDIENTS, INC. 2026 OMNIBUS INCENTIVE PLAN Exhibit 10.1 ALTO INGREDIENTS, INC. 2026 OMNIBUS INCENTIVE PLAN ALTO INGREDIENTS, INC., a Delaware corporation, sets forth herein the terms of its 2026 Omnibus Incentive Plan, as follows: 1. PURPOS

U.S. stock futures were down on Thursday, with several companies experiencing significant drops in pre-market trading. Alto Neuroscience shares fell 13.6% after its Phase 2 clinical trial did not meet statistical significance. Immunovant Inc. also saw an 8.3% decline following the announcement of its Phase 3 study results.